z-logo
open-access-imgOpen Access
Stimulator of Interferon Genes–Associated Vasculopathy With Onset in Infancy
Author(s) -
J Conde Munoz,
M. Rodière,
Nadia Jeremiah,
Frédéric RieuxLaucat,
Anthony Oojageer,
Gillian Rice,
Flore Rozenberg,
Yanick J. Crow,
D. Bessis
Publication year - 2015
Publication title -
jama dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.128
H-Index - 166
eISSN - 2168-6084
pISSN - 2168-6068
DOI - 10.1001/jamadermatol.2015.0251
Subject(s) - medicine , stimulator of interferon genes , pathogenesis , sting , vasculitis , pathology , dermatology , receptor , disease , innate immune system , engineering , aerospace engineering
The type I interferonopathies comprise a recently recognized group of mendelian diseases characterized by an upregulation of type I interferon signaling. These monogenic phenotypes include classic Aicardi-Goutières syndrome and syndromic forms of systemic lupus erythematosus, including familial chilblain lupus and spondyloenchondrodysplasia. Dermatologic features provide a major diagnostic clue to this disease grouping, as exemplified by the recently described stimulator of interferon genes-associated vasculopathy with onset in infancy (SAVI) caused by gain-of-function mutations in TMEM173.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom